Contents

Recent Patents on Anti-Cancer Drug Discovery, Volume 3 - Number 2

Prevention and Treatment of Regimen-Related Mucosal Toxicity

, 3(2): 68 - 75

Joanne M. Bowen


DOI: 10.2174/157489208784638802




Cetuximab: Its Use in Combination with Radiation Therapy and Chemotherapy in the Multimodality Treatment of Head and Neck Cancer

, 3(2): 76 - 83

Timothy D. Wagner and Gary Y. Yang


DOI: 10.2174/157489208784638776




Natural Monoclonal Antibodies and Cancer

, 3(2): 84 - 87

Peter H. Vollmers and Stephanie Brandlein


DOI: 10.2174/157489208784638758




Developments in Targeted Therapy of Advanced Gastrointestinal Stromal Tumors

, 3(2): 88 - 99

Piotr Rutkowski, Malgorzata Symonides, Marcin Zdzienicki and Janusz A. Siedlecki


DOI: 10.2174/157489208784638749




Molecularly Targeted Therapy in Breast Cancer: The New Generation

, 3(2): 100 - 104

Zeina A. Nahleh


DOI: 10.2174/157489208784638794




Anti-CTLA4 Monoclonal Antibody Ipilimumab in the Treatment of Metastatic Melanoma: Recent Findings

, 3(2): 105 - 113

Marko Lens, Pier F. Ferrucci and Alessandro Testori


DOI: 10.2174/157489208784638767




Aurora Kinase Family: A New Target for Anticancer Drug

, 3(2): 114 - 122

Teresa Macarulla, Francisco Javier Ramos and Josep Tabernero


DOI: 10.2174/157489208784638785




Novel Purine Nucleoside Analogues for Hematological Malignancies

, 3(2): 123 - 136

Anna Korycka, Ewa Lech-Maranda and Tadeusz Robak


DOI: 10.2174/157489208784638811




Targeting Vesicle Trafficking: An Important Approach to Cancer Chemotherapy

, 3(2): 137 - 147

Paul K. Wright


DOI: 10.2174/157489208784638730




Patent Selections

, 3(2): 148 - 150

Bentham Science Publishers


DOI: 10.2174/157489208784638721




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science